Gene-Disorder Association · Article
Gene
CYP2D6 Cytochrome P450 Family 2 Subfamily D Member 6 (Gene/Pseudogene)
×
First reported
1994
Supporting publications
17
Manually curated Approved treatment annotated
Association Review
In brief The association between CYP2D6 (Cytochrome P450 Family 2 Subfamily D Member 6 (Gene/Pseudogene)) and Parkinson'S Disease is reported, with clinical genetic testing available.
Sources
1
Clinical variants
0
Symptoms
13
Compounds
11
Trials
180 of 352 via CYP2D6 compounds
Publications
17
Contents
01
At a glance
Association overview A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources 1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
1 source summary
A gene summary alongside the source descriptions it was distilled from.
Request access
04
Parkinson'S Disease
The disorder 7 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Interventions
Therapeutics 11 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
06
Human studies
Clinical trials 352 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
17 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
08
Provenance
References & sources 13 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access